Dipen Mehta has built a notable career as an investment expert, leveraging extensive knowledge in financial markets to guide various investment strategies. With over two decades of experience, he plays a pivotal role in equity and research management, translating market dynamics into actionable insights for his clients. He serves as the managing director at one of India’s leading asset management firms where his leadership not only drives investment performance but also cultivates deep relationships across the industry. His educational background enhances his analytical capabilities, ensuring sound judgment in capital allocation decisions within highly competitive sectors.
Dipen Mehta has built a notable career as an investment expert, leveraging extensive knowledge in financial markets to guide various investment strategies. With over two decades of experience, he plays a pivotal role in equity and research management, translating market dynamics into actionable insights for his clients. He serves as the managing director at one of India’s leading asset management firms where his leadership not only drives investment performance but also cultivates deep relationships across the industry. His educational background enhances his analytical capabilities, ensuring sound judgment in capital allocation decisions within highly competitive sectors.
Equity analysis presents an ongoing opportunity for value extraction, guided by a deep understanding of market fluctuations. Drawing from vast experience, Mehta emphasizes a comprehensive approach that blends rigorous research with strategic foresight. His proactive stance in identifying emerging trends allows for timely capital allocation while navigating the complexities of varying sectors. A distinct focus on fostering client relationships underpins decision-making processes, reflecting both an investor-centric perspective and commitment to long-term wealth creation.
Equity analysis presents an ongoing opportunity for value extraction, guided by a deep understanding of market fluctuations. Drawing from vast experience, Mehta emphasizes a comprehensive approach that blends rigorous research with strategic foresight. His proactive stance in identifying emerging trends allows for timely capital allocation while navigating the complexities of varying sectors. A distinct focus on fostering client relationships underpins decision-making processes, reflecting both an investor-centric perspective and commitment to long-term wealth creation.
| Trades 5981 | Longs Won 3821/5981 63% | Profit Factor 4.22 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $452,866.68 |
| Average Win $141,590.2 | Best Trade (Aug 15) $16.37M | Sharpe Ratio -48.96 |
| Average Loss -$59,401.5 | Worst Trade (Dec 30) -$5.36M | Z-Score -12.17 (100%) |
| Commissions $0 | Avg. Trade Length 1y 7m 1w | Expectancy $69,003.33 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,241 | 15,517 | 13,793 | 12,069 | 10,345 | 8,621 | 6,897 | 5,172 | 3,448 | 1,724 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 40,749 | $6.36M | $13.26M | - | $6.89M | 108.35% | +3.162% |
ABBV AbbVie Inc. | 2,618 | $520,536.46 | $665,914.48 | - | $145,378.02 | 27.93% | +1.375% |
ACGL Arch Capital Group Ltd | 10,633 | $1.02M | $1.02M | - | -$550.79 | -0.05% | -0.184% |
AES AES Corporation | 49,572 | $698,469.48 | $733,913.46 | - | $35,443.98 | 5.07% | -0.101% |
AFL Aflac Inc. | 7,689 | $843,967.35 | $878,622.03 | - | $34,654.68 | 4.11% | -0.41% |
AGG iShares Core U.S. Aggregate Bond ETF | 2,134 | $211,751.56 | $204,960.03 | - | -$6,791.53 | -3.21% | -0.657% |
AGX Argan Inc. | 3,778 | $598,863.87 | $1.51M | - | $914,187.31 | 152.65% | -0.408% |
AJG Arthur J. Gallagher & Co. | 4,866 | $1.12M | $1.18M | - | $67,004.77 | 6% | -0.385% |
ALL Allstate Corporation | 6,070 | $1.27M | $1.53M | - | $255,136.35 | 20.02% | -0.647% |
AM Antero Midstream Corporation | 35,332 | $805,569.6 | $787,373.62 | - | -$18,195.98 | -2.26% | -2.43% |
AMAT Applied Materials, Inc. | 973 | $350,097.33 | $444,079.63 | - | $93,982.3 | 26.84% | -2.655% |
AMCR Amcor plc | 15,643 | $621,809.25 | $670,771.84 | - | $48,962.59 | 7.87% | -0.58% |
AMD Advanced Micro Devices, Inc. | 1,276 | $138,043.85 | $644,162.56 | - | $506,118.71 | 366.64% | -3.121% |
AMGN Amgen Inc. | 742 | $229,344.9 | $283,926.3 | - | $54,581.4 | 23.8% | -2.203% |
AMLP Alerian MLP ETF | 24,254 | $1.14M | $1.35M | - | $217,137.75 | 19.12% | -0.73% |
AMZN Amazon.com Inc | 34,470 | $6.2M | $8.66M | - | $2.46M | 39.72% | -0.489% |
APP AppLovin Corporation Class A Common Stock | 1,543 | $318,706.96 | $485,990.99 | - | $167,284.03 | 52.49% | +3.247% |
APTV Aptiv PLC | 8,161 | $480,030.02 | $370,019.74 | - | -$110,010.28 | -22.92% | +1.865% |
ASML ASML Holding N.V. New York Registry Shares | 467 | $311,077.13 | $792,676.46 | - | $481,599.33 | 154.82% | -1.858% |
ATEC Alphatec Holdings Inc. | 158,570 | $995,760.13 | $1.39M | - | $389,348.82 | 39.1% | -2.782% |